Next Article in Journal / Special Issue
Applications of 19F-NMR in Fragment-Based Drug Discovery
Previous Article in Journal / Special Issue
Protein-Directed Dynamic Combinatorial Chemistry: A Guide to Protein Ligand and Inhibitor Discovery
Article Menu
Issue 7 (July) cover image

Export Article

Open AccessReview
Molecules 2016, 21(7), 811; doi:10.3390/molecules21070811

Targeting Bacterial Dsb Proteins for the Development of Anti-Virulence Agents

Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Kingsbury Drive, Bundoora, Vic 3083, Australia
Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Royal Parade, Parkville, Vic 3052, Australia
Author to whom correspondence should be addressed.
Academic Editors: Raymond S. Norton and Derek J. McPhee
Received: 26 April 2016 / Revised: 21 May 2016 / Accepted: 25 May 2016 / Published: 16 July 2016
(This article belongs to the Special Issue Developments in Fragment-Based Lead Discovery)
View Full-Text   |   Download PDF [2791 KB, uploaded 16 July 2016]   |  


Recent years have witnessed a dramatic increase in bacterial antimicrobial resistance and a decline in the development of novel antibiotics. New therapeutic strategies are urgently needed to combat the growing threat posed by multidrug resistant bacterial infections. The Dsb disulfide bond forming pathways are potential targets for the development of antimicrobial agents because they play a central role in bacterial pathogenesis. In particular, the DsbA/DsbB system catalyses disulfide bond formation in a wide array of virulence factors, which are essential for many pathogens to establish infections and cause disease. These redox enzymes are well placed as antimicrobial targets because they are taxonomically widespread, share low sequence identity with human proteins, and many years of basic research have provided a deep molecular understanding of these systems in bacteria. In this review, we discuss disulfide bond catalytic pathways in bacteria and their significance in pathogenesis. We also review the use of different approaches to develop inhibitors against Dsb proteins as potential anti-virulence agents, including fragment-based drug discovery, high-throughput screening and other structure-based drug discovery methods. View Full-Text
Keywords: disulfide catalysis; DsbA inhibitors; DsbB inhibitors; anti-virulence; fragment-based drug design, antimicrobial resistance disulfide catalysis; DsbA inhibitors; DsbB inhibitors; anti-virulence; fragment-based drug design, antimicrobial resistance

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Smith, R.P.; Paxman, J.J.; Scanlon, M.J.; Heras, B. Targeting Bacterial Dsb Proteins for the Development of Anti-Virulence Agents. Molecules 2016, 21, 811.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top